Director Robert W. Fairbairn filed a Form 4 with the SEC on October 29, 2026, disclosing the acquisition of 1,840 common shares of BlackRock Capital Allocation Term Trust through a transferable subscription rights offering with a transaction date of October 27, 2026.

Key Highlights

  • Reporting person: Robert W. Fairbairn, identified as a Director of BlackRock Capital Allocation Term Trust (NYSE:BCAT)
  • Shares acquired: 1,840 common shares on October 27, 2026, via transaction code X
  • Resulting ownership: 11,044.0268 common shares beneficially owned directly following the transaction
  • Rights exercised: 9,200 Transferable Subscription Rights were used to acquire the 1,840 common shares, with zero rights remaining after the transaction
  • Subscription price: $13.30 per common share, as disclosed in the filing's explanation of responses
  • Rights ratio: One new common share was purchasable for every five Rights held, according to the filing

Fairbairn Participates in BCAT Rights Offering at $13.30 Per Share

According to the Form 4 filing, Director Robert W. Fairbairn acquired 1,840 common shares of BlackRock Capital Allocation Term Trust on October 27, 2026, through the exercise of Transferable Subscription Rights. The filing lists the transaction under transaction code X, with the shares owned directly. Following the transaction, Fairbairn's direct beneficial ownership stands at 11,044.0268 common shares, as reported in Table I of the filing.

The filing's explanation of responses states that on September 10, 2026, the Fund announced the terms of a pro rata rights offering to holders of the Fund's common shares as of the record date of September 25, 2026. According to the filing, "Record Date Shareholders received one Right for each outstanding whole common share held on the record date." The Rights entitled holders to purchase one new common share for every five Rights held. The filing further notes that "any Record Date Shareholder who owns fewer than five common shares as of the close of business on the Record Date will be entitled to subscribe for one common share." The subscription price per common share was $13.30, and the aggregate rights offering covered up to 21,255,200 common shares of the Fund.

Table II of the filing shows that Fairbairn held 9,200 Transferable Subscription Rights, which were exercisable from September 25, 2026, through an expiration date of October 21, 2026, and underlying 1,840 common shares. After the reported transaction, the number of derivative securities beneficially owned is listed as 0. The form was signed by Gladys Chang as Attorney-in-Fact on October 29, 2026.

What Was Disclosed

Director Robert W. Fairbairn reported acquiring 1,840 common shares of NYSE:BCAT on October 27, 2026, by exercising 9,200 Transferable Subscription Rights at $13.30 per share under a pro rata rights offering announced September 10, 2026, bringing his direct beneficial ownership to 11,044.0268 shares.